{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:33:38Z","timestamp":1791495218132,"version":"4.3.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["5-R01-DK098234-09"],"award-info":[{"award-number":["5-R01-DK098234-09"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["5-R01-DK098234-09"],"award-info":[{"award-number":["5-R01-DK098234-09"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>In unadjusted analyses, elevated urinary Dickkopf-3 levels were strongly associated with higher risks of cardiovascular disease, ESKD, AKI, and mortality.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>However, associations were substantially weakened after adjustment for eGFR and albuminuria, suggesting limited prognostic value.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Urinary Dickkopf-3 (uDKK3) is a tubular epithelial-derived profibrotic protein secreted into the urine under tubular stress. It is associated with kidney disease progression in persons with CKD and diabetes and postoperative and contrast-associated AKI. We explored associations of uDKK3 with cardiovascular disease (CVD), kidney, and mortality outcomes within the subset of Systolic Blood Pressure Intervention Trial participants with nondiabetic CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We included 2344 participants with eGFR &lt;60 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      at baseline. We used Cox proportional hazards models to evaluate associations of uDKK3 with CVD (acute decompensated heart failure, myocardial infarction, acute coronary syndrome, stroke, or CVD death), kidney outcomes (incident ESKD, incident AKI, and eGFR decline \u226530%), and all-cause mortality. We used linear mixed models to examine the association of uDKK3 with annual percentage change in eGFR. Models were adjusted for demographic and clinical characteristics, eGFR, and albuminuria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over a median follow-up of 3.5 years, there were 292 CVD, 73 ESKD, 183 AKI, 471 eGFR decline, and 228 mortality events. In multivariable models without adjustment for eGFR and albuminuria, uDKK3 was strongly associated with CVD, ESKD, AKI, eGFR decline \u226530%, and mortality. However, after further adjustment for eGFR and albuminuria, uDKK3 was no longer associated with risks for composite CVD (hazard ratio, 1.07; 95% confidence interval, 0.92 to 1.23), ESKD (0.80; 0.62 to 1.02), AKI (1.01; 0.85 to 1.21), eGFR decline \u226530% (0.88; 0.79 to 0.99), or mortality (1.02; 0.87 to 1.20). For the linear eGFR change outcome, higher uDKK3 also had no association in the fully adjusted model (\u22120.03; \u22120.41 to 0.36).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among individuals with hypertension and nondiabetic CKD, higher uDKK3 appeared to have associations with a greater risk of CVD events, incident ESKD, incident AKI, eGFR decline \u226530%, and mortality but these associations were not independent of eGFR and albuminuria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000000000000413","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:48Z","timestamp":1710288048000},"page":"690-697","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Association of Urinary Dickkopf-3 Levels with Cardiovascular Events and Kidney Disease Progression in Systolic Blood Pressure Intervention Trial"],"prefix":"10.34067","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3228-483X","authenticated-orcid":false,"given":"Vanessa-Giselle","family":"Peschard","sequence":"first","affiliation":[{"name":"University of California, San Francisco, California"},{"name":"Kidney Health Research Collaborative, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, California"},{"name":"Kidney Health Research Collaborative, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7723-7469","authenticated-orcid":false,"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0106-050X","authenticated-orcid":false,"given":"Teresa K.","family":"Chen","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, California"},{"name":"Kidney Health Research Collaborative, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6864-0336","authenticated-orcid":false,"given":"Alexander L.","family":"Bullen","sequence":"additional","affiliation":[{"name":"Division of Nephrology-Hypertension, Department of Medicine, University of California, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasey","family":"Campos","sequence":"additional","affiliation":[{"name":"Kidney Health Research Collaborative, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8902-9576","authenticated-orcid":false,"given":"Michelle M.","family":"Estrella","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, California"},{"name":"Kidney Health Research Collaborative, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-9869","authenticated-orcid":false,"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[{"name":"Division of Nephrology-Hypertension, Department of Medicine, University of California, San Diego, California"},{"name":"Veterans Affairs San Diego Healthcare System, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9559-204X","authenticated-orcid":false,"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, California"},{"name":"Kidney Health Research Collaborative, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"issue":"5","key":"B1-20250823","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.ajkd.2021.03.026","article-title":"The promise of tubule biomarkers in kidney disease: a review","volume":"78","author":"Ix","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B2-20250823","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage","volume":"20","author":"Nath","year":"1992","journal-title":"Am J Kidney Dis."},{"issue":"7","key":"B3-20250823","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1681\/ASN.2013070713","article-title":"Association of urinary injury biomarkers with mortality and cardiovascular events","volume":"25","author":"Sarnak","year":"2014","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B4-20250823","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2215\/CJN.08560816","article-title":"Urine kidney injury biomarkers and risks of cardiovascular disease events and all-cause death: the CRIC study","volume":"12","author":"Park","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B5-20250823","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000499531","article-title":"Urinary biomarkers of tubular damage are associated with mortality but not cardiovascular risk among systolic blood pressure intervention trial participants with chronic kidney disease","volume":"49","author":"Jotwani","year":"2019","journal-title":"Am J Nephrol."},{"issue":"42","key":"B6-20250823","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1093\/eurheartj\/ehz392","article-title":"Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial","volume":"40","author":"Garimella","year":"2019","journal-title":"Eur Heart J."},{"issue":"3","key":"B7-20250823","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2215\/CJN.02780319","article-title":"Urine markers of kidney tubule cell injury and kidney function decline in SPRINT trial participants with CKD","volume":"15","author":"Malhotra","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7","key":"B8-20250823","doi-asserted-by":"crossref","first-page":"e102559","DOI":"10.1371\/journal.pone.0102559","article-title":"Pax6 regulates the expression of Dkk3 in murine and human cell lines, and altered responses to Wnt signaling are shown in FlpIn-3T3 cells stably expressing either the Pax6 or the Pax6(5a) isoform","volume":"9","author":"Forsdahl","year":"2014","journal-title":"PLoS One."},{"issue":"1","key":"B9-20250823","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1038\/s41598-021-88107-9","article-title":"The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population","volume":"11","author":"Piek","year":"2021","journal-title":"Sci Rep."},{"issue":"5","key":"B10-20250823","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/ndt\/gfaa003","article-title":"Dickkopf 3-a novel biomarker of the 'kidney injury continuum","volume":"36","author":"Schunk","year":"2021","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B11-20250823","doi-asserted-by":"crossref","first-page":"e84916","DOI":"10.1172\/jci.insight.84916","article-title":"Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis","volume":"1","author":"Federico","year":"2016","journal-title":"JCI Insight."},{"issue":"3","key":"B12-20250823","doi-asserted-by":"crossref","first-page":"e2155","DOI":"10.1038\/cddis.2016.62","article-title":"Downregulation of renal tubular Wnt\/\u03b2-catenin signaling by Dickkopf-3 induces tubular cell death in proteinuric nephropathy","volume":"7","author":"Wong","year":"2016","journal-title":"Cell Death Dis."},{"issue":"9","key":"B13-20250823","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1517\/14728222.2011.588210","article-title":"Wnt-signaling pathways in progressive renal fibrosis","volume":"15","author":"Nelson","year":"2011","journal-title":"Expert Opin Ther Targets."},{"issue":"10197","key":"B14-20250823","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0140-6736(19)30769-X","article-title":"Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study","volume":"394","author":"Schunk","year":"2019","journal-title":"Lancet."},{"issue":"3","key":"B15-20250823","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40620-020-00910-1","article-title":"Dickkopf-3 in the prediction of contrast media induced acute kidney injury","volume":"34","author":"Seibert","year":"2021","journal-title":"J Nephrol."},{"issue":"12","key":"B16-20250823","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/ndt\/gfab198","article-title":"Urinary Dickkopf-3: a new biomarker for CKD progression and mortality","volume":"36","author":"S\u00e1nchez-\u00c1lamo","year":"2021","journal-title":"Nephrol Dial Transplant."},{"issue":"11","key":"B17-20250823","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1681\/ASN.2018040405","article-title":"Dickkopf-3 (DKK3) in urine identifies patients with short-term risk of eGFR loss","volume":"29","author":"Zewinger","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"23","key":"B18-20250823","first-page":"2294","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"374","author":"Wright","year":"2016","journal-title":"N Engl J Med."},{"issue":"5","key":"B19-20250823","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials."},{"issue":"1","key":"B20-20250823","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med."},{"issue":"4","key":"B21-20250823","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.xkme.2021.02.013","article-title":"Ix JH, Estrella MM: urinary biomarkers and kidney outcomes: impact of indexing versus adjusting for urinary creatinine","volume":"3","author":"Wettersten","year":"2021","journal-title":"Kidney Med."},{"issue":"2","key":"B22-20250823","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"446","key":"B23-20250823","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc."},{"issue":"3","key":"B24-20250823","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41581-020-00343-w","article-title":"WNT-\u03b2-catenin signalling - a versatile player in kidney injury and repair","volume":"17","author":"Schunk","year":"2021","journal-title":"Nat Rev Nephrol."},{"issue":"11","key":"B25-20250823","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/ejhf.1988","article-title":"A combined bioinformatics, experimental and clinical approach to identify novel cardiac-specific heart failure biomarkers: is Dickkopf-3 (DKK3) a possible candidate?","volume":"22","author":"Piek","year":"2020","journal-title":"Eur J Heart Fail."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000000000413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:00:13Z","timestamp":1786478413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000000000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000000000413","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"2024-01-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}